Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

Art therapy can help individuals express thoughts and feelings without relying solely on words, providing a valuable outlet ...

Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...

AbbVie Inc.’s disappointing trial results for its new schizophrenia drug bode well for rival Bristol Myers Squibb Co., ...

Shares of AbbVie plummeted Monday after the company said its schizophrenia drug Emraclidine missed key goals in a pair of trials.

Symptoms of schizophrenia, a serious mental disorder that can include hallucinations and delusions, vary greatly from person to person. One common group of schizophrenia symptoms that doesn’t ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

ED visits related to hallucinogen use are linked to a 21-fold increased risk of schizophrenia spectrum disorder, results of a ...

Vraylar is a once-daily tablet prescribed for certain mental health conditions. Learn when to take it, what foods to avoid, ...

On September 26, the U.S. Food and Drug Administration (FDA) approved a drug called Cobenfy to treat schizophrenia. Cobenfy is a combination of xanomeline and trospium chloride that has a novel ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...